The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Abstract
We reported aldosterone as a novel adipocyte-derived factor that regulates vascular function. We aimed to investigate molecular mechanisms, signaling pathways, and functional significance of adipocyte-derived aldosterone and to test whether adipocyte-derived aldosterone is increased in diabetes mellitus–associated obesity, which contributes to vascular dysfunction. Studies were performed in the 3T3-L1 adipocyte cell line and mature adipocytes isolated from human and mouse (C57BL/6J) adipose tissue. Mesenteric arteries with and without perivascular fat and mature adipocytes were obtained from obese diabetic db/db and control db/+ mice. Aldosterone synthase (CYP11B2; mRNA and protein) was detected in 3T3-L1 and mature adipocytes, which secrete aldosterone basally and in response to angiotensin II (Ang II). In 3T3-L1 adipocytes, Ang II stimulation increased aldosterone secretion and CYP11B2 expression. Ang II effects were blunted by an Ang II type 1 receptor antagonist (candesartan) and inhibitors of calcineurin (cyclosporine A and FK506) and nuclear factor of activated T-cells (VIVIT). FAD286 (aldosterone synthase inhibitor) blunted adipocyte differentiation. In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced. Acetylcholine-induced relaxation in db/db mesenteric arteries containing perivascular fat was improved by eplerenone (mineralocorticoid receptor antagonist) without effect in db/+ mice. Adipocytes possess aldosterone synthase and produce aldosterone in an Ang II/Ang II type 1 receptor/calcineurin/nuclear factor of activated T-cells–dependent manner. Functionally adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes as a putative link between aldosterone and vascular dysfunction in diabetes mellitus–associated obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, the increased aldosterone production by adipocytes in obesity was shown to contribute to the vascular changes associated with this condition (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“For instance, adipocyte-derived aldosterone has emerged as a new paradigm in linking obesity with vascular disease (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Moreover, this study revealed that adipocyte-derived aldosterone regulates vascular function in a paracrine manner.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Adipocytes were found to possess the components necessary for aldosterone synthesis.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
Citations
Cites
Greenstein, A. S., Khavandi, K., Withers, S., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821181 · Cited by 616
Interaction of calcineurin with substrates and targeting proteins
Li, H., Rao, A., & Hogan, P. G. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.011 · Cited by 381
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247
Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp191 · Cited by 241
Adipogenic and lipolytic effects of chronic glucocorticoid exposure
Campbell, J. E., Peckett, A. J., D'souza, A. M., Hawke, T. J., & Riddell, M. C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00045.2010 · Cited by 228
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
Ketonen, J., Jin, S., Martonen, E., & Mervaala, E. M. A. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0661 · Cited by 209
Cited by
Sorted by citations
Items 101–200 of 373
Mineralocorticoid receptors modulate vascular endothelial function in human obesity
Hwang, M.-H., Yoo, J.-K., Luttrell, M., Kim, H.-K., Meade, T. H., English, M., Segal, M. S., & Christou, D. D. (2013) · Clinical Science · doi:10.1042/cs20130200 · Cited by 48
Cat, A. N. D., Callera, G. E., Friederich‐Persson, M., Sánchez, A., Dulak-Lis, M. G., Tsiropoulou, S., Montezano, A. C. I., He, Y., Briones, A. M., Jaisser, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21087-5 · Cited by 48
Self-citationManolis, A. S., Manolis, T. A., Melita, H., & Manolis, A. S. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0924-0 · Cited by 48
Moss, M. E., Carvajal, B. V., & Jaffe, I. Z. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.009 · Cited by 48
Adipose tissue macrophages as a therapeutic target in obesity‐associated diseases
Herrada, A. A., Olate‐Briones, A., Armando Rojas, R., Liu, C., Escobedo, N., & Piesche, M. (2021) · Obesity Reviews · doi:10.1111/obr.13200 · Cited by 48
Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases
Fioretti, F., Testani, J. M., Tio, M. C., Pitt, B., & Butler, J. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.012 · Cited by 51
Silva, M. A. B., Bruder-Nascimento, T. B., Cáu, S. B. D. A., Alves-Lopes, R., Mestriner, F., Fais, R. S., Touyz, R. M., & Tostes, R. C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00269 · Cited by 48
Self-citationOwen, J., & Reisin, E. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0558-9 · Cited by 48
Savarese, G., Schiattarella, G. G., Lindberg, F., Anker, M. S., Bayés‐Genís, A., Bäck, M., Braunschweig, F., Bucciarelli‐Ducci, C., Butler, J., Cannata, A. N., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3676 · Cited by 52
Transient Receptor Potential Melastatin 7 Cation Channel Kinase
Antunes, T. T., Callera, G. E., He, Y., Yogi, Á., Ryazanov, A. G., Ryazanova, L. V., Zhai, A. B., Stewart, D. J., Shrier, A., & Touyz, R. M. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.07021 · Cited by 46
Self-citationLinks between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 52
Pisani, D. F., Béranger, G. E., Corinus, A., Giroud, M., Ghandour, R. A., Altirriba, J., Chambard, J., Mazure, N. M., Bendahhou, S., Duranton, C., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-277475 · Cited by 49
Obesity in kidney disease: A heavyweight opponent
Felizardo, R. J. F. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i3.50 · Cited by 44
Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans
Hosoya, K., Minakuchi, H., Wakino, S., Fujimura, K., Hasegawa, K., Komatsu, M., Yoshifuji, A., Futatsugi, K., Shinozuka, K., Washida, N., et al. (2014) · Kidney International · doi:10.1038/ki.2014.348 · Cited by 43
Obesity: The Perfect Storm for Heart Failure
Lembo, M., Strisciuglio, T., Fonderico, C., Mancusi, C., Izzo, R., Trimarco, V., Bellis, A., Barbato, E., Esposito, G., Morisco, C., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14641 · Cited by 51
Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults
Zhang, T., Zhang, H., Li, S., Li, Y., Liu, Y., Fernandez, C., Harville, E. W., Bazzano, L., He, J., & Chen, W. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06509 · Cited by 43
Slowing the Progression of Diabetic Kidney Disease
Blazek, O., & Bakris, G. L. (2023) · Cells · doi:10.3390/cells12151975 · Cited by 43
Aldosterone and Myocardial Extracellular Matrix Expansion in Type 2 Diabetes Mellitus
Rao, A. D., Shah, R. V., Garg, R., Abbasi, S. A., Neilan, T. G., Perlstein, T. S., Carli, M. F. D., Jerosch‐Herold, M., Kwong, R. Y. K., & Adler, G. K. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.02.060 · Cited by 42
Luo, P., Dematteo, A., Wang, Z., Zhu, L., Wang, A., Kim, H.-S., Pozzi, A., Stafford, J. M., & Luther, J. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2814-8 · Cited by 41
Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest
Martínez‐Martínez, E., Souza‐Neto, F. V., Jiménez‐González, S., & Cachofeiro, V. (2021) · Antioxidants · doi:10.3390/antiox10030406 · Cited by 45
Sahinoz, M., Elijovich, F., Ertuğlu, L. A., Ishimwe, J., Pitzer, A. L., Saleem, M., Mwesigwa, N., Kleyman, T. R., Laffer, C. L., & Kirabo, A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0212 · Cited by 41
Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
Takeda, Y., Demura, M., Kometani, M., Karashima, S., Yoneda, T., & Takeda, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065782 · Cited by 40
da Costa, R. M., Cerqueira, D. M., Bruder‐Nascimento, A., Alves, J. V., Awata, W. M. C., Singh, S., Kufner, A., Prado, D. D. S., Johny, E., Cifuentes-Pagano, E., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21888 · Cited by 41
Shero, J. A., Lindholm, M. E., Sandri, M. F., & Stanford, K. I. (2025) · Circulation Research · doi:10.1161/circresaha.124.325614 · Cited by 45
The endothelial mineralocorticoid receptor
Davel, A. P., Anwar, I. J., & Jaffe, I. Z. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000306 · Cited by 39
Palachai, N., Wattanathorn, J., Muchimapura, S., & Thukham-mee, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5972575 · Cited by 39
From fat to filter: the effect of adipose tissue-derived signals on kidney function
Ahmed, N., Dalmasso, C., Turner, M. B., Arthur, G., Cincinelli, C., & Loria, A. S. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00950-5 · Cited by 42
Hsp90 Blockers Inhibit Adipocyte Differentiation and Fat Mass Accumulation
Desarzens, S., Liao, W.-H., Mammi, C., Caprio, M., & Faresse, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094127 · Cited by 37
Bruder-Nascimento, T. B., Callera, G. E., Montezano, A. C. I., de Chantemèle, E. J. B., Tostes, R. C., & Touyz, R. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.043 · Cited by 37
Self-citationObesity, Sodium Homeostasis, and Arterial Hypertension in Children and Adolescents
Wójcik, M., & Kozioł-Kozakowska, A. (2021) · Nutrients · doi:10.3390/nu13114032 · Cited by 44
Mende, C. W., Samarakoon, R., & Higgins, P. J. (2023) · American Journal of Nephrology · doi:10.1159/000528783 · Cited by 37
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation
Martínez‐Martínez, E., Cachofeiro, V., Rousseau, E., Álvarez, V., Calvier, L., Fernández‐Celis, A., Leroy, C., Miana, M., Jurado-López, R., Briones, A. M., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.007 · Cited by 36
Self-citationVictorio, J. A., Clerici, S. P., Palacios, R., Alonso, M. J., Vassallo, D. V., Jaffe, I. Z., Rossoni, L. V., & Davel, A. P. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07911 · Cited by 36
Obesity, Hypertension, and Bariatric Surgery
Samson, R., Ayinapudi, K., Jemtel, T. H. L., & Oparil, S. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01049-x · Cited by 38
Rami, A. Z. A., Hamid, A. A., Anuar, N. N. M., Aminuddin, A., & Ugusman, A. (2022) · Mediators of Inflammation · doi:10.1155/2022/2734321 · Cited by 37
Buglioni, A., Cannone, V., Sangaralingham, S. J., Heublein, D. M., Scott, C. G., Bailey, K. R., Rodeheffer, R. J., Sarzani, R., & Burnett, J. C. J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002505 · Cited by 36
Kanbay, M., Güldan, M., Özbek, L., Çöpür, S., Covic, A. S., & Covic, A. C. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.014 · Cited by 39
Vascular Mineralocorticoid Receptors
Lother, A., & Hein, L. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07418 · Cited by 34
Obesity and renovascular disease
Zhang, X., & Lerman, L. O. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00547.2014 · Cited by 34
Jia, G., Hill, M. A., & Sowers, J. R. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0066 · Cited by 32
Joshi, H. R., Vastrad, B. M., Joshi, N., Tengli, A., Vastrad, C. M., & Kotturshetti, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.628907 · Cited by 35
Cooper, J. N., Fried, L. F., Tepper, P. G., Barinas‐Mitchell, E., Conroy, M. B., Evans, R. G., Brooks, M. M., Woodard, G. A., & Sutton‐Tyrrell, K. (2013) · Hypertension Research · doi:10.1038/hr.2013.45 · Cited by 33
Even, S., Dulak-Lis, M. G., Touyz, R. M., & Cat, A. N. D. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0013 · Cited by 30
Self-citationKalkman, H. O. (2020) · Pharmaceuticals · doi:10.3390/ph13050092 · Cited by 32
Childhood Obesity: Insight into Kidney Involvement
Carullo, N., Zicarelli, M., Michael, A., Faga, T., Battaglia, Y., Pisani, A., Perticone, M., Costa, D., Ielapi, N., Coppolino, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417400 · Cited by 33
Liu, P., Kong, F., Wang, J., Lu, Q., Xu, H., Qi, T., & Meng, J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.011 · Cited by 30
Ramanjaneya, M., Karteris, E., Chen, J., Ruciński, M., Ziółkowska, A., Ahmed, N., Kagerer, S. M., Jöhren, O., Lehnert, H., Malendowicz, L. K., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00191.2013 · Cited by 30
Faulkner, J., & de Chantemèle, E. J. B. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.09.003 · Cited by 30
Packer, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1377 · Cited by 29
Epigenetic Regulation of the Renin–Angiotensin–Aldosterone System in Hypertension
Takeda, Y., Demura, M., Yoneda, T., & Takeda, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158099 · Cited by 28
Ferreira, N. S., Cáu, S. B. D. A., Silva, M. A. B., Manzato, C. P., Mestriner, F., Matsumoto, T., Carneiro, F. S., & Tostes, R. C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00034 · Cited by 28
Victorio, J. A., Guizoni, D. M., Freitas, I. N., Araújo, T. R., & Davel, A. P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720224 · Cited by 28
Adipokines: Deciphering the cardiovascular signature of adipose tissue
Galley, J. C., Singh, S., Awata, W. M. C., Alves, J. V., & Bruder-Nascimento, T. B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115324 · Cited by 32
Central Adiposity or Hypertension
Packer, M., Butler, J., Lam, C. S. P., Zannad, F. M., Vaduganathan, M., & Borlaug, B. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.036 · Cited by 30
Battson, M. L., Lee, D. M., Jarrell, D. K., Hou, S., Ecton, K. E., Phan, A. B., & Gentile, C. L. (2017) · Journal of Vascular Research · doi:10.1159/000479967 · Cited by 27
Hošková, L., Málek, I., Kautzner, J., Honsová, E., van Dokkum, R. P. E., Husková, Z., Vojtíšková, A., Jíchová, Š., Červenka, L., & Kopkan, L. (2014) · Hypertension Research · doi:10.1038/hr.2014.79 · Cited by 29
Nonsteroidal and Steroidal Mineralocorticoid Antagonists
Harrington, J., Canonico, M. E., Rafei, A. E., Solomon, S. D., Teerlink, J. R., Vaduganathan, M., Zieroth, S. R., Bonaca, M. P., & Sauer, A. J. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.102637 · Cited by 27
Kang, M. I., Yan, L., Li, Y. M., Zhang, W., Wang, H., Tang, A. Z., & Ou, H. S. (2013) · Genetics and Molecular Research · doi:10.4238/2013.november.7.1 · Cited by 26
Hoirisch-Clapauch, S., & Nardi, A. E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.08.011 · Cited by 26
Clerico, A., Zaninotto, M., Passino, C., & Plebani, M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0840 · Cited by 26
Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders
Garg, R., & Adler, G. K. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0567-8 · Cited by 26
Byrd, J. B., & Brook, R. D. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.42 · Cited by 25
Kalkman, H. O., & Smigielski, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04989-0 · Cited by 29
HFpEF and MASLD: converging mechanisms and clinical implications
Capone, F., Häseli, S. P., Liu, L., Strocchi, S., Langenberg, C., Lusis, A. J., Pietzner, M., Muoio, D. M., Rider, O. J., Raman, B., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01257-z · Cited by 35
Metabolic and cardiovascular outcomes of bariatric surgery
Iqbal, Z., Adam, S., Ho, J. H., Syed, A. A., Ammori, B. J., Malik, R. A., & Soran, H. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000696 · Cited by 24
Modulation of Vascular Function by Perivascular Adipose Tissue: Sex Differences
Victorio, J. A., da Costa, R. M., Tostes, R. C., & Davel, A. P. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200701211912 · Cited by 24
Aldosterone: Essential for Life but Damaging to the Vascular Endothelium
Crompton, M., Skinner, L. J., Satchell, S. C., & Butler, M. J. (2023) · Biomolecules · doi:10.3390/biom13061004 · Cited by 26
Kesireddy, V., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Kluwe, B., Effoe, V. S., Echouffo-Tcheugui, J. B., Kalyani, R. R., Sims, M., et al. (2019) · Nutrients · doi:10.3390/nu11050955 · Cited by 23
Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
Vecchiola, A., Fuentes, C., Solar, I., Lagos, C. F., Opazo, M. C., Muñoz‐Durango, N., Riedel, C. A., Owen, G. I., Kalergis, A. M., & Fardella, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00223 · Cited by 23
Biwer, L. A., Carvajal, B. V., Lu, Q. R., Man, J. J., & Jaffe, I. Z. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16911 · Cited by 24
Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor
Parasiliti‐Caprino, M., Bollati, M., Merlo, F. D., Ghigo, E., Maccario, M., & Bo, S. (2022) · Nutrients · doi:10.3390/nu14224735 · Cited by 24
Barrea, L., Verde, L., Camajani, E., Šojat, A. S., Marina, L., Savastano, S., Colao, A., Caprio, M., & Muscogiuri, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02068-6 · Cited by 26
Steroid Metabolomic Signature of Insulin Resistance in Childhood Obesity
Gawlik, A., Shmoish, M., Hartmann, M. F., Wudy, S. A., & Hochberg, Z. (2019) · Diabetes Care · doi:10.2337/dc19-1189 · Cited by 23
Non‐steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney disease
Dhaybi, O. A., & Bakris, G. L. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13983 · Cited by 23
Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity
van der Heijden, C. D. C. C., ter Horst, R., van den Munckhof, I., Schraa, K., Graaf, J. D., Joosten, L. A. B., Danser, A. H. J., Netea, M. G., Deinum, J., Rutten, J. H. W., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa356 · Cited by 22
Association of visceral adiposity index with hypertension (NHANES 2003–2018)
Zhou, H., Li, T., Li, J., Zheng, D., Yang, J., & Zhuang, X. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1341229 · Cited by 22
Ames, M. K., Atkins, C. E., Lee, S., Lantis, A. C., & zumBrunnen, J. R. (2015) · American Journal of Veterinary Research · doi:10.2460/ajvr.76.12.1041 · Cited by 22
Rios, F. J. O., Neves, K. B., Cat, A. N. D., Even, S., Palacios, R., Montezano, A. C. I., & Touyz, R. M. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221002 · Cited by 21
Self-citationObesity-related hypertension and chronic kidney disease: from evaluation to management
Jung, M., & Ihm, S. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.072 · Cited by 24
Lefranc, C., Friederich‐Persson, M., Foufelle, F., Cat, A. N. D., & Jaisser, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062881 · Cited by 20
Jackson, A. M., Benson, L., Savarese, G., Hage, C., Jhund, P. S., Petrie, M. C., Dahlström, U., McMurray, J. J. V., & Lund, L. H. (2022) · JACC Heart Failure · doi:10.1016/j.jchf.2022.04.006 · Cited by 20
Jung, M., & Shin, M. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.271 · Cited by 23
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Bettinetti‐Luque, M., Trujillo‐Estrada, L., García‐Fuentes, E., Andreo‐Lopez, J., Sanchez-Varo, R. M., Garrido‐Sánchez, L., Mediavilla, A. G., López, M. G., García‐Caballero, M., Gutiérrez, A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16243 · Cited by 21
Zhu, J., Chen, Y., Yang, M., Liu, B., Dong, J., Dong, H., Rui, H., & Cheng, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8386 · Cited by 20
Yin, X., Qian, J., Wang, Y., Yang, C., Jia, B., Cheng, Y., Yu, G., & Wang, Y. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1529775 · Cited by 20
Adipocyte Mineralocorticoid Receptor
Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.005 · Cited by 20
Obesity and Heart Failure with Preserved Ejection Fraction
Koutroumpakis, E., Kaur, R., Taegtmeyer, H., & Deswal, A. M. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.02.003 · Cited by 21
B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS
Semler, M. W., Marney, A. M., Rice, T. W., Nian, H., Yu, C., Wheeler, A. P., & Brown, N. J. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.03.017 · Cited by 20
Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?
Lyngsø, K. S., Assersen, K. B., Dalgaard, E. G., Skøtt, O., Jensen, B. L., & Hansen, P. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000345 · Cited by 19
Why do humans have two glucocorticoids: A question of intestinal fortitude
Morris, D. J. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.017 · Cited by 21
RADAKRISHNAN, A., AGRAWAL, S., SINGH, N., Barbieri, A., Shaw, L. J., Gulati, M., & Lala, A. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.01.008 · Cited by 19
Belany, P. A., Kackley, M. L., Zhao, S., Kluwe, B., Buga, A., Crabtree, C. D., Nedungadi, D., Kline, D., Brock, G. N., Simonetti, O. P., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad009 · Cited by 17
Recent advances in the treatment of patients with obesity and chronic kidney disease
Wahab, R. A., COHEN, R. V., & le Roux, C. W. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2203517 · Cited by 22
Effects of canrenone in patients with metabolic syndrome
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., D’Angelo, A., Fogari, E., & Maffioli, P. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.832756 · Cited by 18
DeVallance, E., Branyan, K., Olfert, I. M., Pistilli, E. E., Bryner, R. W., Kelley, E. E., Frisbee, J. C., & Chantler, P. D. (2021) · Experimental Physiology · doi:10.1113/ep089449 · Cited by 18
Ostrominski, J. W., Harrington, J., Claggett, B. L., Filippatos, G. S., Desai, A. S., Jhund, P. S., Henderson, A. D., Lam, C. S. P., Senni, M., Shah, S. J., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.039 · Cited by 17
Protective role of perivascular adipose tissue in the cardiovascular system
Tong, Y., Zuo, Z., Li, X., Li, M., Wang, Z., Guo, X., Wang, X., Sun, Y., Chen, D., & Zhang, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1296778 · Cited by 17
Animal Models in Obesity and Hypertension
Segal‐Lieberman, G., & Rosenthal, T. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0338-3 · Cited by 17
Aldosterone and type 2 diabetes mellitus
Zavatta, G., Casadio, E., Rinaldi, E., Pagotto, U., Pasquali, R., & Vicennati, V. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0065 · Cited by 18
Packer, M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2090 · Cited by 17
Metadata
- Authors
- Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., Sorisky, A., Ooi, T. C., Ruzicka, M., Burns, K. D., & Touyz, R. M.
- Affiliations
- University of Ottawa (CA)
- From the Kidney Research Centre (A.M.B., A.N.D.C., G.E.C., A.Y., D.B., Y.H., J.W.C., K.D.B., R.M.T.), Chronic Disease Program (A.M.G., A.S., T.C.O.), Ottawa Hospital Research Institute, and Division of Nephrology, Department of Medicine (M.R.), University of Ottawa, Ontario, Canada; G.V. (Sonny) Montgomery Veterans Affairs and Division of Endocrinology, Department of Medicine, University of Mississippi Medical Centers, Jackson, MS (C.E.G.-S., E.P.G.-S.); Current address (A.M.B.): Departamento...
- ORCID
- Venue
- Hypertension
- Published
- 2012-05
- Volume
- 59
- Issue
- 5
- Pages
- 1069-1078
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111017518
- Cited by
- 375
- References
- 39
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 26 · 2023: 30 · 2022: 18 · 2021: 28 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 21 · 2016: 27 · 2015: 35 · 2014: 32 · 2013: 27 · 2012: 10
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- aldosterone synthase, calcineurin, NFAT, angiotensin II, angiotensin II type 1 receptor, adipogenesis, vascular dysfunction, db/db mice, perivascular adipose tissue, mesenteric arteries, acetylcholine-induced relaxation, mineralocorticoid receptor, candesartan, eplerenone, autocrine and paracrine signaling
- MeSH terms
- Aldosterone, Animals, Benzimidazoles, Biphenyl Compounds, Cells, Cultured, Diabetic Angiopathies, Disease Models, Animal, Humans, Mice, Inbred C57BL, Obesity, Random Allocation, Sensitivity and Specificity, Tetrazoles, Signal Transduction, Adipocytes, Calcineurin, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review